← Back
$RXRX All transactions

RECURSION PHARMACEUTICALS, INC.

F

$ Value

$16K

Shares

3,796

Price

$4

Filed

May 19

Insider

Name

Khan Najat

Title

Chief R&D Commercial Officer

CIK

0002020969

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-15

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

708,585

Footnotes

Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.

Filing Info

Accession No.

0001601830-25-000084

Form Type

4

Issuer CIK

0001601830

Khan Najat's History

Date Ticker Type Value
2025-12-22 RXRX $549K
2025-11-17 RXRX F $73K
2025-11-05 RXRX A $0
2025-11-05 RXRX A $0
2025-08-18 RXRX $202K
2025-08-15 RXRX F $21K
2025-05-15 RXRX F $16K

Other Insiders at RXRX (90d)

Insider Bought Sold Last
Taylor Ben R
Chief Financial Officer
2026-04-06
Li Dean Y 2026-04-01
Dar Zavain 2026-04-01
Borgeson Blake $93K 2026-04-07
Gibson Christopher $254K 2026-04-07